TACROLIMUS ointment 美国 - 英文 - NLM (National Library of Medicine)

tacrolimus ointment

glenmark pharmaceuticals inc., usa - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

ZONISAMIDE capsule 美国 - 英文 - NLM (National Library of Medicine)

zonisamide capsule

glenmark pharmaceuticals inc., usa - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonisamide capsules are contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonisamide has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.

ESOMEPRAZOLE MAGNESIUM- esomeprazole magnesium capsule, delayed release pellets 美国 - 英文 - NLM (National Library of Medicine)

esomeprazole magnesium- esomeprazole magnesium capsule, delayed release pellets

glenmark pharmaceuticals inc., usa - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - healing of erosive esophagitis esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium delayed-release capsules may be considered. maintenance of healing of erosive esophagitis esomeprazole magnesium delayed-release capsules are indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole magnesium delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults and children 1 year or older. esomeprazole magnesium delayed-release capsules are indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy

GLENMARK-FLUCONAZOLE 50 TABLET 南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

glenmark-fluconazole 50 tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - see ingredients - each tablet contains fluconazole 50,0 mg

GLENMARK-FLUCONAZOLE 150 TABLET 南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

glenmark-fluconazole 150 tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - see ingredients - each tablet contains fluconazole 150,0 mg

GLENMARK-FLUCONAZOLE 200 TABLET 南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

glenmark-fluconazole 200 tablet

glenmark pharmaceuticals south africa (pty) ltd - tablet - see ingredients - each tablet contains fluconazole 200,0 mg

Ezetimibe 10mg Tablets 英国 - 英文 - myHealthbox

ezetimibe 10mg tablets

glenmark pharmaceuticals europe limited - ezetimibe - tablets - 10mg - other lipid modifying agents - primary hypercholesterolaemia homozygous familial hypercholesterolaemia (hofh) homozygous sitosterolaemia (phytosterolaemia)

CANDIVA V GEL 2% w / w (20mg / g) Vaginal Gel 菲律宾 - 英文 - FDA (Food And Drug Administration)

candiva v gel 2% w / w (20mg / g) vaginal gel

glenmark philippines, inc.; distributor: glenmark philippines, inc. - clotrimazole - vaginal gel - 2% w / w (20mg / g)